Double-blind, placebo-controlled comparison of the efficacy of sertraline as treatment for a major depressive episode in patients with remitted schizophrenia

Journal of Clinical Psychopharmacology

Volumn 22, Issue 1, 2002, Pages 20-25

  Addington, Donald ^a   Addington, Jean ^a   Patten, Scott ^a   Remington, Gary ^a   Moamai, Javad ^a   Labelle, Alain ^a   Beauclair, Linda ^a  

^a UNIVERSITY OF CALGARY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

SERTRALINE;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COVARIANCE; DEPRESSION; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FEMALE; HUMAN; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; REMISSION; SCHIZOPHRENIA; SCORING SYSTEM; STATISTICAL ANALYSIS; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; DEPRESSIVE DISORDER, MAJOR; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; PSYCHIATRIC STATUS RATING SCALES; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; SERTRALINE; TREATMENT OUTCOME;

EID: 0036157263     PISSN: 02710749     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004714-200202000-00004     Document Type: Article

References (32)

1. Diagnosis of secondary depression in schizophrenia: Implications for DSM-IV
2. Conditions predisposing to suicide: A review
3. Suicide in chronic schizophrenia
4. Mortality in a cohort of patients with schizophrenia: A record linkage study
5. Antidepressant usage in schizophrenia
6. Treatment of secondary depression in schizophrenia. A double blind, placebo controlled trial of amitriptyline added to perphenazine
7. Adjunctive imipramine in the treatment of post psychotic depression
8. Studies of depressive symptoms in schizophrenia IV, a double blind trial of nortriptyline for depression in chronic schizophrenia
9. Antidepressant drugs in anergic schizophrenia
10. Implications of the efficacy of thiothixene and a chlorpromazine-imipramine combination for depression in schizophrenia
11. Antidepressants in depressed schizophrenic inpatients
12. A controlled clinical study of trazodone in chronic schizophrenic patients with pronounced depressive symptoms
13. Experimental examination of trazodone
14. A double blind, placebo-controlled trial of sertraline for depressive symptoms in stable, chronic schizophrenia
15. A comparative study of sertraline versus imipramine in postpsychotic depressive disorder of schizophrenia
16. Pharmacotherapy of impaired affect in recovering schizophrenia
17. A community-based survey of antidepressant use in persons with schizophrenia
18. Acute treatment response and short-term outcome in schizophrenia: First results of the NIMH treatment strategies in schizophrenia study
19. Reliability and validity of a depression rating scale for schizophrenics. A structured interview guide for the Hamilton Depression Rating Scale
20. Specificity of the Calgary Depression Scale. A structured interview guide for the Hamilton Depression Rating Scale
21. The structured clinical interview for DSM-III-R (SCID) I: History, rationale, and description
22. The structured clinical interview for DSM-III-R (SCID) II multisite test-retest reliability
23. Development of a rating scale for primary depressive illness: A structured interview guide for the Hamilton Depression Rating Scale
24. The positive and negative syndrome scale (PANSS) for schizophrenia
25. The extrapyramidal symptom rating scale
26. Is loss of antidepressant effect during continuation therapy related to placebo effect?
27. Does the change of psychopathology during the placebo period predict the response to subsequent treatment with active medication
28. Canadian clinical practice guidelines for the treatment of schizophrenia
29. Practice guidelines for the treatment of patients with schizophrenia
30. Placebos in clinical trials of psychotropic medication